|
MYO1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.649270E-04 |
| Normal-vs-Stage3 |
4.57159999855961E-08 |
| Normal-vs-Stage4 |
1.785390E-04 |
| Stage1-vs-Stage2 |
6.139600E-02 |
| Stage1-vs-Stage3 |
3.473200E-01 |
| Stage1-vs-Stage4 |
1.734200E-01 |
| Stage2-vs-Stage3 |
3.711400E-01 |
| Stage2-vs-Stage4 |
8.157800E-01 |
| Stage3-vs-Stage4 |
5.660800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
2.739400E-03 |
| Normal-vs-Asian |
3.21800000002703E-06 |
| Caucasian-vs-AfricanAmerican |
4.815000E-01 |
| Caucasian-vs-Asian |
7.603000E-01 |
| AfricanAmerican-vs-Asian |
4.127400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.1493030405727E-11 |
| Normal-vs-Female |
1.11022302462516E-16 |
| Male-vs-Female |
5.891200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.99760216648792E-15 |
| Normal-vs-Age(41-60Yrs) |
2.77309952778637E-10 |
| Normal-vs-Age(61-80Yrs) |
6.9841999994491E-07 |
| Normal-vs-Age(81-100Yrs) |
1.589700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.214180E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.446100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.984800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.831200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.897200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.887600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.522200E-01 |
| Classical-VS-Follicular |
1.343800E-02 |
| Classical-VS-Other |
6.197400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.282360E-01 |
| Tall-VS-Other |
6.135000E-01 |
| Tall-VS-Normal |
4.181400E-04 |
| Follicular-VS-Other |
7.571400E-01 |
| Follicular-VS-Normal |
1.767360E-04 |
| Other-VS-Normal |
7.300200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.65119995454432E-09 |
| Normal-vs-N1 |
2.05300000333253E-08 |
| N0-vs-N1 |
4.110200E-02 |
|
|
